Hiral Anil Shah, Imperial College London; Kallista Chan, London School of Hygiene & Tropical Medicine, and Kris Murray, London School of Hygiene & Tropical Medicine
New research quantifies the link between agricultural practices and malaria transmission in sub-Saharan Africa.
Classical antibiotics that directly kill pathogens are prone to elicit drug-resistance. Targeting host enzymes required for pathogen survival offers can limit the emergence of resistance.
Summer is no fun when mosquitoes are biting. Insect repellent creams, sprays, and lotions are safe and effective but there are alternatives. Here’s what works and what doesn’t!
Treatments for uncomplicated malaria remain mostly robust. But the arsenal against severe malaria and deaths is rapidly weakening. New options are urgently required.
The countries share related populations, economies, ecologies and epidemiologies. This interconnectedness highlights challenges and opportunities for more effective malaria control across the region.
Jaishree Raman, National Institute for Communicable Diseases and Shüné Oliver, National Institute for Communicable Diseases
The South African Malaria Control Programme is one of the few on the continent that is entirely funded by government. The stable source of funding has allowed for steady malaria control interventions.
Jaishree Raman, National Institute for Communicable Diseases and Shüné Oliver, National Institute for Communicable Diseases
The successful development of an effective vaccine against the deadliest form of malaria that is most common in sub-Saharan Africa is indeed a major achievement.
The joint award recognizes the long road to deciphering the biology behind the brain’s ability to sense its surroundings – work that paves the way for a number of medical and biological breakthroughs.
Malaria control must move away from relying too much on insecticides to more innovative and sustainable options. Genetic programming of mosquitoes is one.
A 2015 paper on chicken virus evolution is being taken out of context and used to fuel fears about COVID-19 vaccines. Its lead author aims to clarify the science in hopes of saving lives.
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases